Back to Search Start Over

Enabling Reductions in Maintenance ICS/LABA Therapy Using as Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study

Authors :
E. Garcia Gil
Liam G Heaney
Marc Humbert
Stephanie Korn
M. Keith
B.D. Kent
Shahid Siddiqui
A. de Giorgio Miller
David A. Jackson
B. Cook
Source :
B31. ASTHMA CLINICAL TRIALS.
Publication Year :
2020
Publisher :
American Thoracic Society, 2020.

Subjects

Subjects :
Clinical study
medicine.medical_specialty
chemistry.chemical_compound
chemistry
medicine.drug_class
business.industry
Internal medicine
Ics laba
medicine
Eosinophilic asthma
business
Benralizumab
Anti-inflammatory

Details

Database :
OpenAIRE
Journal :
B31. ASTHMA CLINICAL TRIALS
Accession number :
edsair.doi...........6f987eb4e46e2d09ce966095ed5597b5
Full Text :
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3020
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details